BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33289020)

  • 1. A Clinicopathologic Study on the Role of Estrogen, Progesterone, and Their Classical and Nonclassical Receptors in Cutaneous Neurofibromas of Individuals With Neurofibromatosis 1.
    Rozza-de-Menezes RE; Almeida LM; Andrade-Losso RM; de Souza Vieira G; Siqueira OHK; Brum CI; Riccardi VM; Cunha KS
    Am J Clin Pathol; 2021 Apr; 155(5):738-747. PubMed ID: 33289020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptor expression in neurofibromas.
    McLaughlin ME; Jacks T
    Cancer Res; 2003 Feb; 63(4):752-5. PubMed ID: 12591720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1.
    Kallionpää RA; Peltonen S; Le KM; Martikkala E; Jääskeläinen M; Fazeli E; Riihilä P; Haapaniemi P; Rokka A; Salmi M; Leivo I; Peltonen J
    Lab Invest; 2024 Jan; 104(1):100285. PubMed ID: 37949359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor of ghrelin is expressed in cutaneous neurofibromas of individuals with neurofibromatosis 1.
    Rozza-de-Menezes RE; Gaglionone NC; Andrade-Losso RM; Siqueira OHK; Almeida LM; Peruzini KDS; Guimarães-Filho MAC; Brum CI; Geller M; Cunha KS
    Orphanet J Rare Dis; 2017 Dec; 12(1):186. PubMed ID: 29262839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors.
    Natale CA; Duperret EK; Zhang J; Sadeghi R; Dahal A; O'Brien KT; Cookson R; Winkler JD; Ridky TW
    Elife; 2016 Apr; 5():. PubMed ID: 27115344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone.
    Overdiek A; Winner U; Mayatepek E; Rosenbaum T
    Pediatr Res; 2008 Jul; 64(1):40-3. PubMed ID: 18360307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis 1.
    Kallionpää RA; Ahramo K; Martikkala E; Fazeli E; Haapaniemi P; Rokka A; Leivo I; Harvima IT; Peltonen J; Peltonen S
    Dermatology; 2022; 238(2):329-339. PubMed ID: 34237737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous neurofibromas: Current clinical and pathologic issues.
    Ortonne N; Wolkenstein P; Blakeley JO; Korf B; Plotkin SR; Riccardi VM; Miller DC; Huson S; Peltonen J; Rosenberg A; Carroll SL; Verma SK; Mautner V; Upadhyaya M; Stemmer-Rachamimov A
    Neurology; 2018 Jul; 91(2 Suppl 1):S5-S13. PubMed ID: 29987130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Econazole selectively induces cell death in NF1-homozygous mutant tumor cells.
    Lakes YB; Moye SL; Mo J; Tegtmeyer M; Nehme R; Charlton M; Salinas G; McKay RM; Eggan K; Le LQ
    Cell Rep Med; 2023 Dec; 4(12):101309. PubMed ID: 38086379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells.
    Fishbein L; Zhang X; Fisher LB; Li H; Campbell-Thompson M; Yachnis A; Rubenstein A; Muir D; Wallace MR
    Mol Carcinog; 2007 Jul; 46(7):512-23. PubMed ID: 17393410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and Emerging Imaging Techniques for Neurofibromatosis Type 1-Associated Cutaneous Neurofibromas.
    Li Y; Blakeley JO; Ly I; Berman Y; Lau J; Wolkenstein P; Bergqvist C; Jia W; Milner TE; Katta N; Durkin AJ; Kennedy GT; Rowland R; Romo CG; Fleming J; Kelly KM
    J Invest Dermatol; 2023 Aug; 143(8):1397-1405. PubMed ID: 37330718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.
    Nguyen HTL; Kohl E; Bade J; Eng SE; Tosevska A; Al Shihabi A; Tebon PJ; Hong JJ; Dry S; Boutros PC; Panossian A; Gosline SJC; Soragni A
    Cell Rep Methods; 2024 May; 4(5):100772. PubMed ID: 38744290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous Neurofibromas.
    Ly I; Romo CG; Gottesman S; Kelly KM; Kornacki D; York Z; Lee SY; Rhodes SD; Staedtke V; Steensma MR; Blakeley JO; Wolkenstein P
    J Invest Dermatol; 2023 Aug; 143(8):1388-1396. PubMed ID: 37294242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular Origin, Tumor Progression, and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with
    Radomska KJ; Coulpier F; Gresset A; Schmitt A; Debbiche A; Lemoine S; Wolkenstein P; Vallat JM; Charnay P; Topilko P
    Cancer Discov; 2019 Jan; 9(1):130-147. PubMed ID: 30348676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.
    Church C; Fay CX; Kriukov E; Liu H; Cannon A; Baldwin LA; Crossman DK; Korf B; Wallace MR; Gross AM; Widemann BC; Kesterson RA; Baranov P; Wallis D
    Acta Neuropathol Commun; 2024 Jun; 12(1):102. PubMed ID: 38907342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinicopathological characteristics of lipomatous neurofibromas in neurofibromatosis 1: An investigation of 229 cutaneous neurofibromas and a systematic review of the literature.
    Rozza-de-Menezes RE; Brum CAI; Gaglionone NC; de Sousa Almeida LM; Andrade-Losso RM; Paiva BVB; Faveret PLS; da Silva AV; Siqueira OHK; Riccardi VM; Cunha KS
    J Cutan Pathol; 2018 Oct; 45(10):743-753. PubMed ID: 29959804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.
    Rhodes SD; McCormick F; Cagan RL; Bakker A; Staedtke V; Ly I; Steensma MR; Lee SY; Romo CG; Blakeley JO; Sarin KY
    J Invest Dermatol; 2023 Aug; 143(8):1358-1368. PubMed ID: 37245145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.
    Cannon A; Chen MJ; Li P; Boyd KP; Theos A; Redden DT; Korf B
    Orphanet J Rare Dis; 2018 Feb; 13(1):31. PubMed ID: 29415745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular wall cells contribute to tumourigenesis in cutaneous neurofibromas of patients with neurofibromatosis type 1. A comparative histological, ultrastructural and immunohistochemical study.
    Friedrich RE; Holstein AF; Middendorff R; Davidoff MS
    Anticancer Res; 2012 May; 32(5):2139-58. PubMed ID: 22593502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.